Spatial separation of the processing and MHC class I loading compartments for cross-presentation of the tumor-associated antigen HER2/neuby human dendritic cells-Reference-Cited by-同舟云学术

Spatial separation of the processing and MHC class I loading compartments for cross-presentation of the tumor-associated antigen HER2/neuby human dendritic cells

Published:2015-05-26 Issue:11 Volume:4 Page:e1047585
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Baleeiro Renato B,Rietscher René,Diedrich Andrea,Czaplewska Justyna A,Lehr Claus-Michael,Scherließ Regina,Hanefeld Andrea,Gottschaldt Michael,Walden Peter

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2015.1047585

Reference51 articles.

1. Cross-Priming of Naive Cd8 T Cells against Melanoma Antigens Using Dendritic Cells Loaded with Killed Allogeneic Melanoma Cells

2. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.

3. Dendritic cells are accessory cells for the development of anti-trinitrophenyl cytotoxic T lymphocytes.

4. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation of Poly-Lactic-Co-Glycolic Acid Nanoparticles in a Dry Powder Formulation for Pulmonary Antigen Delivery;Pharmaceutics;2021-08-03

2. Synthesis of a fructose decorated PAGE-b-PEG-b-PLGA polymer with subsequent formulation of nanoparticles;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2020-07

3. Human in vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway;Nature Communications;2018-07-02

4. Combining R-DOTAP and a particulate antigen delivery platform to trigger dendritic cell activation: Formulation development and in-vitro interaction studies;International Journal of Pharmaceutics;2017-10

5. Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications;OncoImmunology;2017-08-30